GenSci-143

N/A

Report date: 2026/05/25 10:37:18

Base Information

Drug NameGenSci-143

Drug Alias NameGenSci143GenSci-143

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linker

Mechanisms of ActionAnti-CD276Anti-PSMA

TargetsCD276 antigenProstate-Specific Membrane Antigen

Therapy Area/IndicationsSolid tumoursProstatic Neoplasms, Castration-Resistant

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesChangchun GeneScience Pharmaceuticals Co Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesChangchun GeneScience Pharmaceuticals Co Ltd

Inactive CompaniesN/A

Active IndicationsSolid tumoursProstatic Neoplasms, Castration-Resistant

Inactive IndicationsN/A

Other Information

ATC CodeN/A